These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 10893735)

  • 1. [A study of the tolerability and effectiveness of nicardipine retard in cognitive deterioration of vascular origin].
    González-González JA; Lozano R
    Rev Neurol; 2000 Apr 16-30; 30(8):719-28. PubMed ID: 10893735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An experimental, randomized, double-blind, placebo-controlled clinical trial to infestigate the effect of nicardipine on cognitive function in patients with vascular dementia. Spanish group of nicardipine study in vascular dementia].
    Rev Neurol; 1999 May 1-15; 28(9):835-45. PubMed ID: 10390744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of nicardipine versus placebo in the prevention of cognitive deterioration in patients with transient ischemic attack].
    Moltó JM; Falip R; Martín R; Insa R; Pastor I; Matías-Guiu J
    Rev Neurol; 1995; 23(119):54-8. PubMed ID: 8548644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicardipine use in cerebrovascular disease: a review of controlled clinical studies.
    Amenta F; Lanari A; Mignini F; Silvestrelli G; Traini E; Tomassoni D
    J Neurol Sci; 2009 Aug; 283(1-2):219-23. PubMed ID: 19303080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicardipine: a hypotensive dihydropyridine-type calcium antagonist with a peculiar cerebrovascular profile.
    Amenta F; Tomassoni D; Traini E; Mignini F; Veglio F
    Clin Exp Hypertens; 2008 Nov; 30(8):808-26. PubMed ID: 19021030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galantamine treatment of vascular dementia: a randomized trial.
    Auchus AP; Brashear HR; Salloway S; Korczyn AD; De Deyn PP; Gassmann-Mayer C;
    Neurology; 2007 Jul; 69(5):448-58. PubMed ID: 17664404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR): preliminary analysis of 6-month data from > 10,000 patients and review of the literature.
    Shlyakhto E
    Curr Med Res Opin; 2007 Nov; 23 Suppl 5():S13-8. PubMed ID: 18093409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular mild cognitive impairment is highly prevalent after lacunar stroke but does not increase over time: a 2-year follow-up study.
    Rasquin SM; van Oostenbrugge RJ; Verhey FR; Lodder J
    Dement Geriatr Cogn Disord; 2007; 24(5):396-401. PubMed ID: 17938568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new method for quantifying the cognitive impairment. Its application in patients with vascular dementia.
    López-Pousa S; Mercadal J; Secades JJ; Lozano M; Martí AM; Vilata J; Lozano R
    Neurologia; 1997 Oct; 12(8):339-42. PubMed ID: 9401397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nicardipine-induced gingival hyperplasia].
    Pascual-Castroviejo I; Pascual Pascual SI
    Neurologia; 1997 Jan; 12(1):37-9. PubMed ID: 9131913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vascular factors and progression of cognitive decline in elderly people].
    Bidzan L; Bidzan M
    Psychiatr Pol; 2005; 39(5):987-95. PubMed ID: 16358597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cognitive impairment secondary to degenerative dementia. Effectiveness of oxiracetam therapy.
    Rozzini R; Zanetti O; Bianchetti A
    Acta Neurol (Napoli); 1993 Feb; 15(1):44-52. PubMed ID: 8456595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Working memory disturbances in patients with major depression after ECT treatment].
    Datka W; Siwek M; Dudek D; Maczka G; Zieba A
    Psychiatr Pol; 2007; 41(3):339-49. PubMed ID: 17900050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of the group reminiscence approach in patients with vascular dementia.
    Ito T; Meguro K; Akanuma K; Ishii H; Mori E
    Dement Geriatr Cogn Disord; 2007; 24(1):48-54. PubMed ID: 17565213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicardipine in the prevention of migraine headaches.
    Romeu Bes J
    Clin Ther; 1992; 14(5):672-7. PubMed ID: 1468086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicardipine in the treatment of outpatients with cerebrovascular disorders.
    Lozano R; Balaguer A
    Clin Ther; 1991; 13(4):496-9. PubMed ID: 1934002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits.
    Chouinard S; Stip E; Poulin J; Melun JP; Godbout R; Guillem F; Cohen H
    Curr Med Res Opin; 2007 Mar; 23(3):575-83. PubMed ID: 17355738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged cognitive dysfunction in survivors of critical illness.
    Sukantarat KT; Burgess PW; Williamson RC; Brett SJ
    Anaesthesia; 2005 Sep; 60(9):847-53. PubMed ID: 16115244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of behavioral disorders in dementia with risperidone in psychogeriatric out-patients].
    Kurz A; Delius-Stute H; Rettig K; Schwalen S
    MMW Fortschr Med; 2003 Oct; 145 Suppl 3():89-95. PubMed ID: 15490773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.